Arenz A, Klein M, Fiehe K. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med.
1996;62:548 - 551.
Mizuno N, Kawakami K, Morita E. Competitive inhibition between 4'-substituted pyridoxine analogues and pyridoxal for pyridoxal kinase from mouse brain.
J Nutr Sci Vitaminol (Tokyo).
1980;26:535 - 543.
Wada K, Ishigaki S, Ueda K, et al. An antivitamin B6, 4'-methoxypyridoxine, from the seed of
Ginkgo biloba
L.
Chem Pharm Bull (Tokyo).
1985;33:3555 - 3557.
Yagi M, Wada K, Sakata M, et al. Studies on the constituents of edible and medicinal plants. IV. Determination of 4-O-methylpyridoxine in serum of the patient with gin-nan food poisoning [in Japanese; English abstract].
Yakugaku Zasshi.
1993;113:596 - 599.
Arenz A, Klein M, Fiehe K. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med.
1996;62:548 - 551.
A to Z Drug Facts
[book on CD-ROM]. 2nd ed. St. Louis, Mo: Facts and Comparisons; 2000.
Takanaga H, Ohnishi A, Murakami H, et al. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects.
Clin Pharmacol Ther.
2000;67:201 - 214.
Monostory K, Vereczkey L, Levai F, et al. Ipriflavone as an inhibitor of human cytochrome P450 enzymes.
Br J Pharmacol.
1998;123:605 - 610.
Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam.
Ann Intern Med.
1996;125:940 - 941.
Bourgeois BF, Dodson WE, Ferrendelli JA. Interactions between primidone, carbamazepine, and nicotinamide.
Neurology.
1982;32:1122 - 1126.
Bourgeois BF, Dodson WE, Ferrendelli JA. Interactions between primidone, carbamazepine, and nicotinamide.
Neurology.
1982;32:1122 - 1126.
Krause KH, Bonjour JP, Berlit P, et al. Biotin status of epileptics.
Ann N Y Acad Sci.
1985;447:297 - 313.
Said HM, Redha R, Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs.
Am J Clin Nutr.
1989;49:127 - 131.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109 - 112.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109 - 112.
Reynolds EH. Mental effects of anticonvulsants, and folic acid metabolism.
Brain.
1968;91:197 - 214.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352 - 356.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726 - 735.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism.
1997;46:959 - 962.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Wahl TO, Gobuty AH, Lukert BP. Long-term anticonvulsant therapy and intestinal calcium absorption.
Clin Pharmacol Ther.
1981;30:506 - 512.
Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
J Clin Endocrinol Metab.
1984;58:1003 - 1009.
Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
J Clin Endocrinol Metab.
1984;58:1003 - 1009.
Carter BL, Garnett WR, Pellock JM, et al. Effect of antacids on phenytoin bioavailability.
Ther Drug Monit.
1981;3:333 - 340.
McElnay JC, Uprichard G, Collier PS. The effect of activated dimethicone and a proprietary antacid preparation containing this agent on the absorption of phenytoin.
Br J Clin Pharmacol. 1982;13:501 - 505.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia.
1998;39:1216 - 1225.
Coulter DL. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity [letter].
Lancet.
1984;1:689.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Dreifuss FE, Langer DH. Hepatic considerations in the use of antiepileptic drugs.
Epilepsia.
1987;28(suppl 2):S23 - S29.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Freeman JM, Vining EP, Cost S, et al. Does carnitine administration improve the symptoms attributed to anticonvulsant medications? A double-blinded, crossover study.
Pediatrics.
1994;93:893 - 895.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia.
1998;39:1216 - 1225.
Hahn TJ, Hendin BA, Scharp CR, et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.
N Engl J Med. 1972;287:900 - 904.
Hahn TJ, Hendin BA, Scharp CR, et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.
N Engl J Med. 1972;287:900 - 904.
Jubiz W, Haussler MR, McCain TA, et al. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.
J Clin Endocrinol Metab.
1977;44:617 - 621.
Brodie MJ, Boobis AR, Dollery CT, et al. Rifampicin and vitamin D metabolism.
Clin Pharmacol Ther.
1980;27:810 - 814.
Williams C, Netzloff M, Folkerts L, et al. Vitamin D metabolism and anticonvulsant therapy: effect of sunshine on incidence of osteomalacia.
South Med J.
1984;77:834 - 836, 842.
Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy.
Am J Obstet Gynecol.
1993;168:923 - 928.
Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency.
Am J Obstet Gynecol.
1993;168:884 - 888.
Último revisado julio 2012 por EBSCO CAM Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.